These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32316911)

  • 21. Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT.
    Palmer R; Dimairo M; Latimer N; Cross E; Brady M; Enderby P; Bowen A; Julious S; Harrison M; Alshreef A; Bradley E; Bhadhuri A; Chater T; Hughes H; Witts H; Herbert E; Cooper C
    Health Technol Assess; 2020 Apr; 24(19):1-176. PubMed ID: 32369007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome.
    Greiss Hess L; Fitzpatrick SE; Nguyen DV; Chen Y; Gaul KN; Schneider A; Lemons Chitwood K; Eldeeb MA; Polussa J; Hessl D; Rivera S; Hagerman RJ
    J Dev Behav Pediatr; 2016 Oct; 37(8):619-28. PubMed ID: 27560971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impacts of a shared book-reading intervention for Italian-speaking children with developmental language disorder.
    Lavelli M; Barachetti C; Majorano M; Florit E; Brotto C; Miottello P
    Int J Lang Commun Disord; 2019 Jul; 54(4):565-579. PubMed ID: 30729644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial.
    Palmer R; Dimairo M; Cooper C; Enderby P; Brady M; Bowen A; Latimer N; Julious S; Cross E; Alshreef A; Harrison M; Bradley E; Witts H; Chater T
    Lancet Neurol; 2019 Sep; 18(9):821-833. PubMed ID: 31397288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of AFQ056 on language learning in fragile X syndrome.
    Berry-Kravis E; Abbeduto L; Hagerman R; Coffey CS; Cudkowicz M; Erickson CA; McDuffie A; Hessl D; Ethridge L; Tassone F; Kaufmann WE; Friedmann K; Bullard L; Hoffmann A; Veenstra-VanderWeele J; Staley K; Klements D; Moshinsky M; Harkey B; Long J; Fedler J; Klingner E; Ecklund D; Costigan M; Huff T; Pearson B;
    J Clin Invest; 2023 Aug; 134(5):. PubMed ID: 37651202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined social communication therapy at home and in education for young autistic children in England (PACT-G): a parallel, single-blind, randomised controlled trial.
    Green J; Leadbitter K; Ellis C; Taylor L; Moore HL; Carruthers S; James K; Taylor C; Balabanovska M; Langhorne S; Aldred C; Slonims V; Grahame V; Parr J; Humphrey N; Howlin P; McConachie H; Couteur AL; Charman T; Emsley R; Pickles A
    Lancet Psychiatry; 2022 Apr; 9(4):307-320. PubMed ID: 35305746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis.
    Aranow C; Cush J; Bolster MB; Striebich CC; Dall'era M; Mackay M; Olech E; Frech T; Box J; Keating R; Wasko MC; St Clair W; Kivitz A; Huang W; Ricketts P; Welch B; Callahan S; Spychala M; Boyle K; York K; Keyes-Elstein L; Goldmuntz E; Diamond B; Davidson A
    Rheumatology (Oxford); 2020 Jul; 59(7):1505-1513. PubMed ID: 31628482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Social Communication Intervention Project: a randomized controlled trial of the effectiveness of speech and language therapy for school-age children who have pragmatic and social communication problems with or without autism spectrum disorder.
    Adams C; Lockton E; Freed J; Gaile J; Earl G; McBean K; Nash M; Green J; Vail A; Law J
    Int J Lang Commun Disord; 2012; 47(3):233-44. PubMed ID: 22512510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an expressive language sampling procedure in fragile X syndrome: a pilot study.
    Berry-Kravis E; Doll E; Sterling A; Kover ST; Schroeder SM; Mathur S; Abbeduto L
    J Dev Behav Pediatr; 2013 May; 34(4):245-51. PubMed ID: 23669871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial.
    Stein EA; Illingworth DR; Kwiterovich PO; Liacouras CA; Siimes MA; Jacobson MS; Brewster TG; Hopkins P; Davidson M; Graham K; Arensman F; Knopp RH; DuJovne C; Williams CL; Isaacsohn JL; Jacobsen CA; Laskarzewski PM; Ames S; Gormley GJ
    JAMA; 1999 Jan; 281(2):137-44. PubMed ID: 9917116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of Fast ForWord Language intervention in school-age children with language impairment: a randomized controlled trial.
    Gillam RB; Loeb DF; Hoffman LM; Bohman T; Champlin CA; Thibodeau L; Widen J; Brandel J; Friel-Patti S
    J Speech Lang Hear Res; 2008 Feb; 51(1):97-119. PubMed ID: 18230858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive training for children and adolescents with fragile X syndrome: a randomized controlled trial of Cogmed.
    Hessl D; Schweitzer JB; Nguyen DV; McLennan YA; Johnston C; Shickman R; Chen Y
    J Neurodev Disord; 2019 Apr; 11(1):4. PubMed ID: 30982467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parent-implemented early language intervention programme for late talkers: parental communicative behaviour change and child language outcomes at 3 and 4 years of age.
    Kruythoff-Broekman A; Wiefferink C; Rieffe C; Uilenburg N
    Int J Lang Commun Disord; 2019 May; 54(3):451-464. PubMed ID: 30680870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An intervention to improve the quality of life in children of parents with serious mental illness: the Young SMILES feasibility RCT.
    Abel KM; Bee P; Gega L; Gellatly J; Kolade A; Hunter D; Callender C; Carter LA; Meacock R; Bower P; Stanley N; Calam R; Wolpert M; Stewart P; Emsley R; Holt K; Linklater H; Douglas S; Stokes-Crossley B; Green J
    Health Technol Assess; 2020 Nov; 24(59):1-136. PubMed ID: 33196410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the effects of communication intervention for developmental pragmatic language impairments: a signal-generation study.
    Adams C; Lloyd J; Aldred C; Baxendale J
    Int J Lang Commun Disord; 2006; 41(1):41-65. PubMed ID: 16272002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome.
    Heussler H; Cohen J; Silove N; Tich N; Bonn-Miller MO; Du W; O'Neill C; Sebree T
    J Neurodev Disord; 2019 Aug; 11(1):16. PubMed ID: 31370779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of maternal gesture use in speech use by children with fragile X syndrome.
    Hahn LJ; Zimmer BJ; Brady NC; Swinburne Romine RE; Fleming KK
    Am J Speech Lang Pathol; 2014 May; 23(2):146-59. PubMed ID: 24686460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An exploratory trial of the effectiveness of an enhanced consultative approach to delivering speech and language intervention in schools.
    Mecrow C; Beckwith J; Klee T
    Int J Lang Commun Disord; 2010; 45(3):354-67. PubMed ID: 20144009
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.